[go: up one dir, main page]

MX2022010725A - Una composicion efectiva para el cuidado personal anti-acne. - Google Patents

Una composicion efectiva para el cuidado personal anti-acne.

Info

Publication number
MX2022010725A
MX2022010725A MX2022010725A MX2022010725A MX2022010725A MX 2022010725 A MX2022010725 A MX 2022010725A MX 2022010725 A MX2022010725 A MX 2022010725A MX 2022010725 A MX2022010725 A MX 2022010725A MX 2022010725 A MX2022010725 A MX 2022010725A
Authority
MX
Mexico
Prior art keywords
acne
personal care
care composition
effective anti
composition
Prior art date
Application number
MX2022010725A
Other languages
English (en)
Inventor
Bharath Palanisamy
Sayandip Mukherjee
Sandip Bhanudas Pathak
Ajay Singh Negi
Original Assignee
Unilever Ip Holdings B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Ip Holdings B V filed Critical Unilever Ip Holdings B V
Publication of MX2022010725A publication Critical patent/MX2022010725A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con un método y una composición para prevenir o tratar el acné mediante inhibición selectiva de la bacteria P. acnes. Esto se administra al utilizar una composición que comprende endolisinas derivadas de fagos P. acnes donde los activos se mantienen en condiciones como el uso de polímeros no iónicos y un intervalo específico de electrolitos y pH que aseguran la máxima eficacia de inhibición.
MX2022010725A 2020-03-02 2021-02-18 Una composicion efectiva para el cuidado personal anti-acne. MX2022010725A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20160349 2020-03-02
PCT/EP2021/054002 WO2021175606A1 (en) 2020-03-02 2021-02-18 An effective anti-acne personal care composition

Publications (1)

Publication Number Publication Date
MX2022010725A true MX2022010725A (es) 2022-09-23

Family

ID=69743104

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010725A MX2022010725A (es) 2020-03-02 2021-02-18 Una composicion efectiva para el cuidado personal anti-acne.

Country Status (5)

Country Link
US (1) US20230106068A1 (es)
EP (1) EP4114352A1 (es)
CN (1) CN115461034B (es)
MX (1) MX2022010725A (es)
WO (1) WO2021175606A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3149203A1 (fr) * 2023-06-02 2024-12-06 L'oreal Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane
AU2024299926A1 (en) 2023-07-27 2026-02-05 Topaz Biosciences, Inc. Cell wall hydrolases targeting c. acnes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248324B1 (en) * 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US20100029765A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Labortories Limited Topical aqueous composition comprising tretinoin
CN102482655B (zh) * 2009-06-26 2018-04-10 莱桑多公司 抗微生物剂
WO2013091775A2 (de) * 2011-12-21 2013-06-27 Merck Patent Gmbh Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe
WO2016130024A1 (en) * 2015-02-13 2016-08-18 Supreme Biotechnologies Limited Endolysin expression platform
EP3328417A4 (en) * 2015-07-31 2019-02-06 The Regents of The University of California MYCOBACTERIUM LYSTERASE: A NEW TREATMENT FOR AKNE
EP3458079A4 (en) * 2016-05-15 2020-03-04 Regents of the University of California COMPOSITIONS AND METHODS FOR TREATING ACNE
JP6815006B2 (ja) * 2016-11-01 2021-01-20 株式会社桃谷順天館 アクネ菌株選択的抗菌剤
EP3774855B1 (en) * 2018-06-13 2024-08-28 Unilever Global IP Limited An antimicrobial composition for selectively inhibiting growth of p. acnes bacteria
CN110722464B (zh) 2018-06-13 2022-01-18 长沙理工大学 可正前角加工的有序微槽结构pcd砂轮的制造工艺
US12516309B2 (en) * 2019-10-31 2026-01-06 University Of Maryland, College Park Method of treating infections by bacteriolytic enzymes and manufacture thereof

Also Published As

Publication number Publication date
US20230106068A1 (en) 2023-04-06
WO2021175606A1 (en) 2021-09-10
EP4114352A1 (en) 2023-01-11
CN115461034A (zh) 2022-12-09
CN115461034B (zh) 2024-09-27

Similar Documents

Publication Publication Date Title
MX2022010725A (es) Una composicion efectiva para el cuidado personal anti-acne.
EP4616902A3 (en) Nerve stimulation for treating migraine and other headache conditions
DE60202727D1 (de) Inhibition von Histondeacetylase zur Behandlung von Herzhypertrophie
EP4021860A4 (en) MICROORGANISMS FOR TREATMENT OF WASTE, WATER OR SOIL OR FOR ANIMAL FEED
MX2020012467A (es) Una composicion antimicrobiana para inhibir selectivamente el crecimiento de bacteria p. acnes.
MY207568A (en) Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
MX2021004645A (es) Método y sistema para tratar agua de riego.
WO2018175749A3 (en) LRP1 BINDING AGENTS AND USES THEREOF
EA201390489A1 (ru) Применение хелатирующего агента и антимикробных пептидных соединений
MX2024013133A (es) Metodo y composicion para prevenir o tratar la miopia
RU2013103507A (ru) Лечение келоидов
BR112018002548A2 (pt) composição antimicrobiana com eficácia contra endoesporos
PH12022550486B1 (en) Pathogenic control compositions and methods
EA201390487A1 (ru) Антимикробный белок
MX2011013115A (es) Uso de monoclorourea para tratar aguas industriales.
WO2020086807A8 (en) Antipathogenic polypeptides
CN105594741B (zh) 一种硝普钠在控制蓝藻水华中的应用
SA519401281B1 (ar) معالجة ومعادلة مياه صابورة
MX2022012808A (es) Metodos y sistemas para el control de bacterias en biopeliculas.
JP2021165284A5 (es)
MX389556B (es) Una composicion antimicrobiana
PH12012000153A1 (en) Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation
RU2011151224A (ru) Способ профилактики и лечения некробактериоза парнокопытных животных
Mehmood et al. Occurrence, Challenges, and Control Strategies for Biofilms in Irrigation Networks of Modern Agriculture
PL414890A1 (pl) Środek aktywujący